Skip to main content
Clinical Trials/CTRI/2020/05/025442
CTRI/2020/05/025442
Not yet recruiting
Phase 2

A prospective clinical study to explore the oral Fluconazole resistance in Tinea Corporis

Dr ASVINI J0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr ASVINI J
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr ASVINI J

Eligibility Criteria

Inclusion Criteria

  • 1\.Single or multiple annular erythematous plaques
  • 2\.KOH mount positive for Tinea corporis
  • 3\.No previpous exposure to Fluconazole
  • 4\.Comorbidities like Diabetes mellitus, obesity and other endocrine disorders.

Exclusion Criteria

  • 1\.Large cofluent lesions.
  • 2\.History of previous exposure to Fluconazole
  • 3\.Patients on medications like steroide, antihistamines, aspirin, immunomodulators,statins,NSAIDS.
  • 4\.Patients on chronic medications for TB, HIV, Leprosy

Outcomes

Primary Outcomes

Not specified

Similar Trials